Verily Life Sciences company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

verily.com

Verily Life Sciences has not claimed their Profile.

1 of Verily Life Sciences's competitors have claimed theirs

Here’s why one competitor wins customers.

Digital Diagnostics logo

During the pandemic, the importance of remote patient monitoring soared. However, for its long term success and utilization to be assured, it must be simple for both physicians and their patients,

Our partnership with Redox means Withings now integrates into practically every EHR system allowing physicians and hospitals to easily send Withings devices to their patients and access insights into their daily blood pressure, weight, sleep patterns, heart rates, and more. With Redox’s one connection and our range of devices, designed to easily integrate into patients’ everyday lives, the entire process is effortless for all involved, and many of the common frictions associated with remote patient monitoring are removed.

Verily Life Sciences’s Customers

See why customers chose Verily Life Sciences's products and services. Verily Life Sciences's customers include OncImmune, Onduo, and Onduo.

OncImmune Logo

Oncimmune is an early cancer detection company. It has pioneered the development of autoantibody assay technologies that have the potential to allow c…

Onduo Logo

Onduo is a digital healthcare company that uses data to help people with diabetes live their best life. Initially, Onduo will focus on the type 2 diab…

Onduo Logo

Onduo is a digital healthcare company that uses data to help people with diabetes live their best life. Initially, Onduo will focus on the type 2 diab…

Gilead Sciences Logo

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious dise…

Work for Verily Life Sciences?

Compete with Verily Life Sciences?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Work for Verily Life Sciences?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

Cardionomic Logo
Cardionomic

Cardionomic addresses Acute Decompensated Heart Failure's root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality.

N
Neuspera Medical

Neuspera Medical is a medical device startup that leverages exclusively licensed mid-field powering techniques to engineer miniaturized injectable neuromodulation technologies, sometimes referred to as electroceuticals. Neuspera's implantable module is more than 100 times smaller than other neuromodulation devices and may substantially reduce implant procedure complexity, time, patient complication, and post-surgical pain. Neuspera Medical is committed to bringing forward implantable medical device technology that will improve lives of patients battling with chronic illness.

S
ShiraTronics

ShiraTronics develops an approach to treat migraine headaches. The company is focused on developing and clinically testing its neuromodulation technology

SetPoint Medical Logo
SetPoint Medical

SetPoint Medical is developing a bioelectronic medicine platform using a small implanted device that activates the body's natural Inflammatory Reflex and produces a systemic anti-inflammatory effect.

L
LivaNova

LivaNova is a medical device company in the treatment of cardiovascular diseases. The company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

B
Brainsgate

BrainsGate develops a technology for modulation of cerebro-vascular properties through neuro-stimulation of the spheno-palatine ganglion. Affected properties are central to many CNS disorders - blood vessel permeability and blood flow. Currently targeted applications include treatment of ischemic stroke and drug delivery to the CNS through modifying the permeability of the blood brain barrier. The Company has initiated clinical trials, delivering a chemotherapeutic agent to primary brain tumor patients.)

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.